Celgene Corp (NASDAQ:CELG)

During the Trading Day
117.66 +0.67 / +0.57%
As of 4:14pm ET
Day’s Change
During After-Hours   Switch to standard view »
118.15 +0.49 / +0.42%
 
Volume: 84.2K

Stock Price Forecast

The 26 analysts offering 12-month price forecasts for Celgene have a median target of 143.00, with a high estimate of 163.00 and a low estimate of 74.00. The median estimate represents a +21.54% increase from the last price of 117.66.

Analyst Recommendations

The current consensus among 30 polled investment analysts is to Buy stock in Celgene. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$1.06
Sales
$2.1B
Reporting Date
Apr 23

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 4.86%
 
 
 
 
 
 
Growthannually 29.90%
 
 
 
 
 
 

Sales

Growthquarterly 1.54%
 
 
 
 
 
 
Growthannually 21.67%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account